Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
HK$5.02 Mil
% of Total Estimate Gain
30.07%

Emerging Markets Equity Index Fund's BeOne Medicines Ltd Holding Summary

As of 2025-03-31, Emerging Markets Equity Index Fund held - shares of BeOne Medicines Ltd(HKSE:06160), totaling N/A. This investment constitutes 0% of their stock portfolio, and Emerging Markets Equity Index Fund now holds 0% of the outstanding BeOne Medicines Ltd(HKSE:06160) stock.

The initial trade took place in 2023Q4. And since then Emerging Markets Equity Index Fund has made 3 purchases of HKSE:06160, at an average price of HK$107.66, for a total of 155,034.00 shares. In addition, there have been 1 sales at an average price of HK$140.03 for 155,034.00 shares. Based on historical transaction data and HKSE:06160's current price of HK$180.90, Emerging Markets Equity Index Fund's estimated gain on his HKSE:06160 holdings is HK$5.02 Mil, reflecting a 30.07% gain to date.

Emerging Markets Equity Index Fund HKSE:06160 (HK$180.90) Holding Chart

Emerging Markets Equity Index Fund HKSE:06160 (HK$180.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price HK$-/Share
Shares Sold 0 Average Price HK$-/Share
Current Price HK$0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1